L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Status
- RECRUITING
- Phase
- PHASE1
A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC
- Status
- COMPLETED
- Phase
- N/A
To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Integrin αvβ6-targeted PET in Malignant Tumors
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.
- Status
- COMPLETED
- Phase
- N/A
NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Quest for Tumour Evolution of Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes
- Status
- COMPLETED
- Phase
- PHASE2